AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin

Cancer Research

Volumn 67, Issue 21, 2007, Pages 10491-10500

  Teng, Yun ^a   Girvan, Allicia C ^b   Casson, Lavona K ^a   Pierce Jr , William M ^a   Qian, Mingwei ^a   Thomas, Shelia D ^a   Bates, Paula J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; AS 1411; CYCLIN E; CYCLIN E2; DIMETHYLARGININASE; NUCLEOLIN; OLIGONUCLEOTIDE; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 5; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN TARGETING; ST7 GENE; TRANSCRIPTION REGULATION; TRANSCRIPTION REPRESSION; TUMOR SUPPRESSOR GENE;

ARGININE; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION; HUMANS; MALE; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHOPROTEINS; PROTEIN METHYLTRANSFERASES; PROTEIN TRANSPORT; RNA-BINDING PROTEINS;

EID: 35948945681     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4206     Document Type: Article

References (51)

1. Pestourie C, Tavitian B, Duconge F. Aptamers against extracellular targets for in vivo applications. Biochimie 2005;87:921-30.
2. Cogoi S, Ballico M, Bonora GM, Xodo LE. Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding. Cancer Gene Ther 2004;11:465-76.
3. Bates PJ, Kahlon JB, Thomas SD, Trent JO, Miller DM. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem 1999;274:26369-77.
4. Xu X, Hamhouyia F, Thomas SD, et al. Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem 2001;276:43221-30.
5. Dapic V, Bates PJ, Trent JO, Rodger A, Thomas SD, Miller DM. Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry 2002;41:3676-85.
6. Dapic V, Abdomerovic V, Marrington R, et al. Biophysical and biological properties of quadruplex oligodeoxyribonucleotides. Nucleic Acids Res 2003;31:2097-107.
7. Girvan AC, Teng Y, Casson LK, et al. AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin. Mol Cancer Ther 2006;5:1790-9.
8. Laber D, Bates P, Trent J, Barnhart K, Taft B, Miller D. Long term clinical response in renal cell carcinoma patients treated with quadruplex forming oligonucleotides. Clin Cancer Res 2005;11:9088S.
9. Miller D, Laber D, Bates P, Trent J, Taft B, Kloecker GH. Extended phase I study of AS1411 in renal and non-small cell lung cancers. Ann Oncol 2006;17:ix147-8.
10. Srivastava M, Pollard HB. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 1999;13:1911-22.
11. Storck S, Shukla M, Dimitrov S, Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007;41:125-44.
12. Mongelard F, Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol 2007;17:80-6.
13. Sirri V, Roussel P, Gendron MC, Hernandez-Verdun D. Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent. Cytometry 1997;28:147-56.
14. Derenzini M, Sirri V, Trere D, Ochs RL. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995;73:497-502.
15. Mi Y, Thomas SD, Xu X, Casson LK, Miller DM, Bates PJ. Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem 2003;278:8572-9.
16. Hovanessian AG, Puvion-Dutilleul F, Nisole S, et al. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 2000;261:312-28.
17. Dumler I, Stepanova V, Jerke U, et al. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol 1999;9:1468-76.
18. Legrand D, Vigie K, Said EA, et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 2004;271:303-17.
19. Shibata Y, Muramatsu T, Hirai M, et al. Nuclear targeting by the growth factor midkine. Mol Cell Biol 2002;22:6788-96.
20. Larrucea S, Cambronero R, Gonzalez-Rubio C, et al. Internalization of factor J and cellular signalization after factor J-cell interaction. Biochem Biophys Res Commun 1999;266:51-7.
21. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003;163:871-8.
22. Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 2006;107:3564-71.
23. Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005;123:49-63.
24. Otake Y, Soundararajan S, Sengupta TK, et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007;109:3069-75.
25. Grinstein E, Wernet P, Snijders PJ, et al. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J Exp Med 2002;196:1067-78.
26. Fu Z, Fenselau C. Proteomic evidence for roles for nucleolin and poly(ADP-ribosyl) transferase in drug resistance. J Proteome Res 2005;4:1583-91.
27. Powell DW, Rane MJ, Joughin BA, et al. Proteomic identification of 14-3-3ζ as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol Cell Biol 2003;23:5376-87.
28. Hanakahi LA, Sun H, Maizels N. High affinity interactions of nucleolin with G-G-paired rDNA. J Biol Chem 1999;274:15908-12.
29. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004;24:9630-45.
30. Sun A, Shanmugam I, Song J, Terranova PF, Thrasher JB, Li B. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer. Prostate 2007;67:976-88.
31. Bedford MT, Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 2005;18:263-72.
32. Pahlich S, Zakaryan RP, Gehring H. Protein arginine methylation: cellular functions and methods of analysis. Biochim Biophys Acta 2006;1764:1890-903.
33. Krause CD, Yang ZH, Kim YS, Lee JH, Cook JR, Pestka S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther 2007;113:50-87.
34. Blanchet F, Schurter BT, Acuto O. Protein arginine methylation in lymphocyte signaling. Curr Opin Immunol 2006;18:321-8.
35. McBride AE, Silver PA. State of the arg: protein methylation at arginine comes of age. Cell 2001;106:5-8.
36. Boisvert FM, Cote J, Boulanger MC, Richard S. A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics 2003;2:1319-30.
37. Yanagida M, Shimamoto A, Nishikawa K, Furuichi Y, Isobe T, Takahashi N. Isolation and proteomic characterization of the major proteins of the nucleolinbinding ribonucleoprotein complexes. Proteomics 2001;1:1390-404.
38. Cimato TR, Tang J, Xu Y, et al. Nerve growth factor-mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1. J Neurosci Res 2002;67:435-42.
39. Raman B, Guarnaccia C, Nadassy K, et al. N(ω)-arginine dimethylation modulates the interaction between a Gly/Arg-rich peptide from human nucleolin and nucleic acids. Nucleic Acids Res 2001;29:3377-84.
40. Pellar GJ, DiMario PJ. Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain. Chromosoma 2003;111:461-9.
41. Lefebvre S, Burlet P, Viollet L, et al. A novel association of the SMN protein with two major nonribosomal nucleolar proteins and its implication in spinal muscular atrophy. Hum Mol Genet 2002;11:1017-27.
42. Mikhaylova LM, Boutanaev AM, Nurminsky DI. Transcriptional regulation by Modulo integrates meiosis and spermatid differentiation in male germ line. Proc Natl Acad Sci U S A 2006;103:11975-80.
43. Gonsalvez GB, Rajendra TK, Tian L, Matera AG. The Sm-protein methyltransferase, dart5, is essential for germ-cell specification and maintenance. Curr Biol 2006;16:1077-89.
44. Fabbrizio E, El Messaoudi S, Polanowska J, et al. Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep 2002;3:641-5.
45. Angelov D, Bondarenko VA, Almagro S, et al. Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. EMBO J 2006;25:1669-79.
46. Masumi A, Fukazawa H, Shimazu T, et al. Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation. Oncogene 2006;25:5113-24.
47. Grinstein E, Du Y, Santourlidis S, Christ J, Uhrberg M, Wernet P. Nucleolin regulates gene expression in CD34-positive hematopoietic cells. J Biol Chem 2007;282:12439-49.
48. Kim JM, Sohn HY, Yoon SY, et al. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 2005;11:473-82.
49. Ancelin K, Lange UC, Hajkova P, et al. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 2006;8:623-30.
50. Hooi CF, Blancher C, Qiu W, et al. ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix. Oncogene 2006;25:3924-3.
51. Pal S, Baiocchi RA, Byrd JC, Grever MR, Jacob ST, Sif S. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 2007;26:3558-69.